Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To evaluate the potential usefulness of 68Ga/18F-PSMA/PSFA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PSMA-related disease patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:
• \- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled PSMA PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Locations
Other Locations
China
The First Affiliated Hospital of University of Science and Technology of China
RECRUITING
Hefei
Tianjin Medical University General Hospital
RECRUITING
Tianjin
Contact Information
Primary
Haonan Yu, MD
dreamadam@126.com
+8613821000597
Time Frame
Start Date: 2020-09-01
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 500
Treatments
Single Group Assignment
Each subject receive a single intravenous injection of 68Ga/18F-PSMA/PSFA, and undergo PET/CT imaging within the specificed time.
Related Therapeutic Areas
Sponsors
Leads: Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital